John Ryan - Jul 12, 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role: Director
Signature: /s/ John Ryan
Stock symbol: UNCY
Transactions as of: Jul 12, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/12/2021, 05:15 PM
Next filing: Nov 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	UNCY	Common Stock						58.1K	Jul 12, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	UNCY	Employee Stock Option (right to buy)							Jul 12, 2021	Common Stock	11.6K	$0.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of stock options vested on August 1, 2019, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on August 1, 2022.